Come up with a name for your new list and we'll add to it:
Aragon Pharmaceuticals was acquired by
Johnson & Johnson on August 19, 2013.
Aragon Pharmaceuticals is a small-molecule drug discovery company focused on developing medicines for the treatment of hormonally-driven cancers. These cancers eventually become resistant to existing …